PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Zivo Bioscience Inc. Warrants (ZIVOW)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

Sector

Healthcare

IPO Date

May 28, 2021

Highlights

Market Cap

$35.33M

Total Revenue (TTM)

$67.22K

Gross Profit (TTM)

$21.95K

EBITDA (TTM)

-$11.77M

Year Range

$0.12 - $2.38

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Zivo Bioscience Inc. Warrants, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%SeptemberOctoberNovemberDecember2025February
285.00%
10.30%
ZIVOW (Zivo Bioscience Inc. Warrants)
Benchmark (^GSPC)

Returns By Period

Zivo Bioscience Inc. Warrants had a return of -15.24% year-to-date (YTD) and 322.38% in the last 12 months.


ZIVOW

YTD

-15.24%

1M

2.67%

6M

285.00%

1Y

322.38%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of ZIVOW, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-8.65%-15.24%
20241,500.00%-25.78%-15.79%-32.50%-16.67%-11.11%140.00%54.17%-34.46%31.96%103.13%39.77%4,442.50%
202310.36%-16.47%-17.94%8.14%-4.78%0.00%-12.49%-4.91%-10.26%-45.40%-26.41%-77.78%-94.81%
2022-24.44%-1.44%-8.10%8.80%24.45%-15.15%-5.28%21.44%-29.11%33.74%-13.14%10.03%-18.06%
202176.46%-28.66%-16.87%12.42%1.00%-10.91%4.46%10.58%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 85, ZIVOW is among the top 15% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ZIVOW is 8585
Overall Rank
The Sharpe Ratio Rank of ZIVOW is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of ZIVOW is 9999
Sortino Ratio Rank
The Omega Ratio Rank of ZIVOW is 9999
Omega Ratio Rank
The Calmar Ratio Rank of ZIVOW is 9191
Calmar Ratio Rank
The Martin Ratio Rank of ZIVOW is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Zivo Bioscience Inc. Warrants (ZIVOW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ZIVOW, currently valued at 0.29, compared to the broader market-2.000.002.000.291.74
The chart of Sortino ratio for ZIVOW, currently valued at 6.62, compared to the broader market-4.00-2.000.002.004.006.006.622.35
The chart of Omega ratio for ZIVOW, currently valued at 1.93, compared to the broader market0.501.001.502.001.931.32
The chart of Calmar ratio for ZIVOW, currently valued at 2.23, compared to the broader market0.002.004.006.002.232.61
The chart of Martin ratio for ZIVOW, currently valued at 5.20, compared to the broader market0.0010.0020.0030.005.2010.66
ZIVOW
^GSPC

The current Zivo Bioscience Inc. Warrants Sharpe ratio is 0.29. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Zivo Bioscience Inc. Warrants with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.29
1.74
ZIVOW (Zivo Bioscience Inc. Warrants)
Benchmark (^GSPC)

Dividends

Dividend History


Zivo Bioscience Inc. Warrants doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-23.00%
0
ZIVOW (Zivo Bioscience Inc. Warrants)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Zivo Bioscience Inc. Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zivo Bioscience Inc. Warrants was 97.70%, occurring on Nov 27, 2023. Recovery took 124 trading sessions.

The current Zivo Bioscience Inc. Warrants drawdown is 23.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.7%Jul 13, 2021484Nov 27, 2023124Dec 24, 2024608
-37%Dec 26, 20241Dec 26, 20245Jan 3, 20256
-36%Jan 6, 20259Jan 30, 2025
-14.97%Jun 11, 20211Jun 11, 202112Jun 29, 202113
-12.28%Jun 3, 20211Jun 3, 20212Jun 7, 20213

Volatility

Volatility Chart

The current Zivo Bioscience Inc. Warrants volatility is 78.49%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2025February
78.49%
3.07%
ZIVOW (Zivo Bioscience Inc. Warrants)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Zivo Bioscience Inc. Warrants over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Zivo Bioscience Inc. Warrants.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab